Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients.
Kirsebom BE, Richter G, Nordengen K, Aarsland D, Bråthen G, Tijms BM, Visser PJ, Nilsson J, Selnes P, Kramberger MG, Winblad B, Waterloo K, Gísladóttir B, Blennow K, Fladby T. Kirsebom BE, et al. Among authors: winblad b. Brain Commun. 2022 Sep 24;4(5):fcac244. doi: 10.1093/braincomms/fcac244. eCollection 2022. Brain Commun. 2022. PMID: 36262371 Free PMC article.
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K. Mattsson N, et al. Among authors: winblad b. JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064. JAMA. 2009. PMID: 19622817
[New diagnostic criteria for Alzheimer disease].
Aarsland D, Rongve A, Fladby T, Testad I, Kivipelto M, Winblad B. Aarsland D, et al. Among authors: winblad b. Tidsskr Nor Laegeforen. 2011 Nov 15;131(22):2224-5. doi: 10.4045/tidsskr.11.1028. Tidsskr Nor Laegeforen. 2011. PMID: 22085942 Free article. Norwegian. No abstract available.
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study.
Winblad B, Andreasen N, Minthon L, Floesser A, Imbert G, Dumortier T, Maguire RP, Blennow K, Lundmark J, Staufenbiel M, Orgogozo JM, Graf A. Winblad B, et al. Lancet Neurol. 2012 Jul;11(7):597-604. doi: 10.1016/S1474-4422(12)70140-0. Epub 2012 Jun 6. Lancet Neurol. 2012. PMID: 22677258 Clinical Trial.
1,201 results